FDA Has Broad Regulatory Options for Mixing Covid Boosters

Oct. 19, 2021, 1:36 AM UTC

U.S. vaccine regulators have broad authority to allow mix-and-match Covid-19 vaccine boosters under their emergency powers, even if Johnson & Johnson and other companies don’t apply for it.

The Food and Drug Administration appears poised to clear heterologous boosting, which would allow someone who’s eligible for a booster to get an additional shot that’s different from their original vaccine. Preliminary results from a National Institutes of Health study indicate mixing Covid-19 vaccines as a booster can produce the same or even more antibodies compared with using the same vaccine for all shots. The study found the strongest antibody response ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.